Revolution Medicines

RVMDNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$43.054 B

$200.87 +0.50%

Close of 8 Oct 2026

As of 8 Oct 2026, Revolution Medicines (RVMD) has a market capitalization of $43.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3630 by revenue

Earnings

-$1.13B

Loss-making

Shares outstanding

214,336,418

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Revolution Medicines lists more than one class of stock. Company figures above cover all classes combined.

RVMDW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#3ModernaMRNA$78.4B
#4Argenx SeARGX$57.6B
#5Revolution MedicinesRVMD$43.1B
#6BiogenBIIB$32.8B
#7BioNTech SEBNTX$23.9B

What if Revolution Medicines were worth as much as…

Open the what-if tool →

Gold $29.0T

$135,278.00

Per share 673× higher

Bitcoin $1.65T

$7,684.32

Per share 38.3× higher

Nvidia $5.72T

$26,701.14

Per share 133× higher

Or at a round number

$100.0B $200.0B $500.0B $1.00T

Where these numbers come from

Share counts and financials for Revolution Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Oct 2026. Read the methodology.